新加坡国立癌症中心、杜克-新加坡大学医学研究院与新加坡综合医院的科学家合作已经在了解乳腺纤维腺瘤的分子基础研究中取得了一项重大突破。研究小组用先进的DNA测序技术识别出近60%的纤维腺瘤病例中关键基因MED12发生突变。他们的研究结果已发表在Nature Genetics杂志上。纤维腺瘤是育龄妇女最常见的良性乳房肿瘤,在新加坡,每年影响着成千上万的妇女。在世界范围内,据估计,每年有数百万妇女被诊断为纤 National Cancer Institute in Singapore, Duke - University of Singapore Medical Institute and Singapore General Hospital scientists have made a major breakthrough in understanding the molecular basis of breast fibroadenoma. The team used advanced DNA sequencing technology to identify mutations in the key gene MED12 in nearly 60% of fibroadenomas. Their findings have been published in Nature Genetics. Fibroadenomas are the most common benign breast tumors of women of childbearing age, affecting thousands of women each year in Singapore. Globally, it is estimated that millions of women are diagnosed with fibrosis every year